Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S063000, C514S337000, C549S214000, C549S270000, C546S281700
Reexamination Certificate
active
06872747
ABSTRACT:
A novel class of decalactones with the general formula (I) and their stereoisomers is disclosed. A method for the synthesis of the decalactones of general formula (I) and the use of the decalactones in pharmaceutical compositions is also described.
REFERENCES:
Edrada et al, Online analysis of xestodecalactones A-C, novel bioactive metabolites from the fungusPenicillium cf. montanenseand their subsequent isolation from the spongeXestospongia exigua' Journal of Natural Products (2002), 65(11 1598-1604.
Bringmann Gerhard
Edrada Ru Angelie
Gunter Eckhard
Heubes Markus
Prokosch Peter
Biotecmarin GmbH
Goodwin & Procter LLP
Owens Amelia A.
LandOfFree
Decalactones, method for making, and pharmaceuticals there from does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Decalactones, method for making, and pharmaceuticals there from, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Decalactones, method for making, and pharmaceuticals there from will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418564